Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|7|4|269-288

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.7, Iss.4, 2007-12, pp. : 269-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting 7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 538-554

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

By Geerts Hugo  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 59-65

Informa Healthcare

Access to resources Recommend Favorite

Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia

By Wallace Tanya L.   Bertrand Daniel  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 139-155

Informa Healthcare

Access to resources Recommend Favorite

Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3797-3806

Bentham Science Publishers

Access to resources Recommend Favorite